Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide

Author： Chatzistamou Ioulia   Schally Andrew   Varga Jozsef   Groot Kate   Armatis Patricia   Bajo Ana  

Publisher： Springer Publishing Company

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.127, Iss.11, 2001-11, pp. : 645-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inhibition of Growth of Androgen-independent DU-145 Prostate Cancer In Vivo by Luteinising Hormone-releasing Hormone Antagonist Cetrorelix and Bombesin Antagonists

By Limonta P.   Pratesi G.   Moretti R.M.   Montagnani Marelli M.   Motta M.   Dondi D.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1134-1135

Elsevier

Access to resources Recommend Favorite

Antineoplastic Action of Growth Hormone-Releasing Hormone (GHRH) Antagonists

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 56-63

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Growth of Androgen-independent DU-145 Prostate Cancer In Vivo by Luteinising Hormone-releasing Hormone Antagonist Cetrorelix and Bombesin Antagonists RC-3940-II and RC-3950-II

By Jungwirth A.   Pinski J.   Galvan G.   Halmos G.   Szepeshazi K.   Cai R.Z.   Groot K.   Vadillo-Buenfil M.   Schally A.V.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1141-1148

Elsevier

Access to resources Recommend Favorite

Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro

By Jaszberenyi Miklos   Schally Andrew   Block Norman   Zarandi Marta   Cai Ren-Zhi   Vidaurre Irving   Szalontay Luca   Jayakumar Arumugam   Rick Ferenc  

Targeted Oncology, Vol. 8, Iss. 4, 2013-12 ,pp. : 281-290

Springer Publishing Company

Access to resources Recommend Favorite

Comments to Inhibition of Growth of Androgen-independent DU-145 Prostate Cancer In Vivo by Luteinising Hormone-releasing Hormone Antagonist Cetrorelix and Bombesin Antagonists RC-3940-II and RC-3950-II, Jungwirth et al., Eur J Cancer 1997, 33(7), 114

By Schally A.V.   Jungwirth A.   Comaru-Schally A.M.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1135-1136

Elsevier

Access to resources Recommend Favorite